PhaseRx Inc (PZRXQ)
0.0002
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
PhaseRx Cash from Operations (TTM): -12.82M for Sept. 30, 2017
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| September 30, 2017 | -12.82M |
| June 30, 2017 | -12.80M |
| March 31, 2017 | -11.64M |
| December 31, 2016 | -9.811M |
| Date | Value |
|---|---|
| September 30, 2016 | -8.277M |
| June 30, 2016 | -7.278M |
| March 31, 2016 | -6.25M |
| December 31, 2015 | -5.98M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| FluoroPharma Medical Inc | -0.8801M |
| RenovaCare Inc | -4.126M |
| Xeno Transplants Corp | -- |
| Entia Biosciences Inc | -0.7151M |
| Regenerx Biopharmaceuticals Inc | -0.8237M |